Whether managing diabetes, exploring weight management options, or both, we are committed to supporting our patients every step of the way with compassionate and expert care
On the 29th, Seoul National University Hospital announced that a joint research teamcomprising Professor Seon-ha Baek's team from Neurosurgery, Professor Jong-ryeol Roh's team from Otolaryngology at Cha Bundang Medical Center, and researcher Jae-wang Lee from Log-Syncpublished a review paper analyzing the effects of long-term administration of GLP-1 class obesity drugs on systemic metabolism
See our detailed provider switching guide
In a head-to-head trial disclosed late last year, Eli Lillys existing drug tirzepatide (the active ingredient in diabetes medication Mounjaro and obesity treatment Zepbound) outperformed Wegovy, with an average 20.2% lost body weight compared to 13.7%
These studies evaluate sleep patterns, delta wave activity, hormonal signaling, withdrawal symptoms, and behavioral responses
Theyll review your medical history and ask questions about your symptoms, which may include: Advertisement The provider will also conduct a physical examination
